EVIDENCE bLOG - Return On Focus Return On Focus | https://returnonfocus.com | Return On Focus

What We Think

EVIDENCE bLOG

Our evidence-based marketing approach provides us with a unique lens to observe and provide insights and commentary on industry news and common client experiences. Please note that any similarities of the events and insights provided here to your current brand situation are purely intentional and should not be considered coincidental. If you see yourself or your brand in any of the blog posts below, feel free to comment and tell us about your experiences.

Earning a seat at the table

Well, I’m sure this post won’t win me many new friends among my fellow pharma vendors, but here goes anyway…

Lately I’ve noticed a new trend where vendor partners bring numerous people to a meeting and all of the partners take seats at the main meeting table.  This, in and of itself, doesn’t seem like a big deal.  However, at many of these meetings, there is not enough room for all of the attendees to sit at the table.  In these instances, I watch in stunned silence as clients take seats along the back walls or in corners, while their vendors stay in their seats at the main table.

These clients refuse to pull rank and make their vendor partners feel bad in a public forum, which makes them good and sensitive human beings.  So, for my clients who are too polite to say what should be said, let me do it for you. Read On

Majority of DTC Advertising Still Only Stimulates an ‘Inquiry’ NOT a Request – ROF Normative Update

DTC Advertising Actions

Back in 2010, I authored a blog post using the patient data that my then 4-year old company had amassed challenging the conventional wisdom that direct-to-consumer advertising (DTCA) is effective at activating a brand request by patients exposed to the advertising. Read On

Six Essential Elements of Successful Specialty Brand Support Services

Number SixIt seems like every new product launching today is a specialty pharmaceutical that requires access via a network of specialty pharmacies. This access system introduces a hurdle not only for the patient and prescriber, but also for the manufacturer – streamlining the process from prescription generation by the physician to medication acquisition by the patient. Read On

Follow us on
Pinterest Twitter slideshare
Contact Us
XXX

Powered by WordPress